$ECOX Rolling Brief - Updated December 16, 2018. Extracts

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
199
$ECOX Rolling Brief - Updated December 16, 2018. Extracts From Official Filings & PRs + Analysis From Observations [recent updates in bold].

New President - John English of Palm Beach, FL.

Name change to Eco Innovation Group, Inc on July 18, 2018.

Legacy subsidiaries Haydin Group Enterprises (Split Endings), Expressions Property Limited,LP and Expressions Chiropractic and Rehab Center, PA reverted to being private entities and the respective share exchange agreements entered into previously were unwound.

The 2018 Q2 and new company disclosure was filed on September 12, 2018.

The 2018 Q3 - including new acquisition and asset disclosures (see below) - was filed on November 19, 2018.

Accordingly, the company should be upgraded again from "Pink Limited Information" to "OTC Pink Current" in the very near future.

The Company is considered to be a "Going Concern"

Ticker change to ECOX approved by FINRA effective midnight September 25/26, 2018.

Eco Innovation Group, Inc reinstated as a Florida business on October 19, 2018.

http://search.sunbiz.org/Inquiry/CorporationS...0000638430

Executive Assistant - Shari McAuley - hired and Company Profile at otcmarkets.com updated week ending December 14, 2018.

As of June 30, 2018, the new President Mr English purchased common stock in a private transaction.

On August 29, 2018, the Company conducted a reverse split of its common stock in a ratio of 1 share for every 1,000 issued and outstanding, reducing Mr. English’s beneficial ownership of common stock to 77,500 shares.

Beneficial Ownership of Shares:

- John English:

-- Preferred: 15,000,000 (50%)
-- Common: 77,500

- Heritage Funding, Inc. of San Diego, CA:

-- Preferred: 15,000,000 (50%)
-- Common: 77,500

The share structure post-reverse split was as anticipated - with no dilution.

The Transfer Agent updated the Verified Company Profile in a timely manner as at November 30, 2018.

Authorized Shares: 2,100,000,000 as at November 30, 2018

Outstanding Shares: 2,830,680 as at November 30, 2018

Restricted: 1,208,800 as at November 30, 2018

Unrestricted: 1,621,880 as at November 30, 2018

Held at DTC: 1,441,009 as at November 30, 2018

There has been no dilution of Common Unrestricted shares in 2017 or in 2018 to date.

The next update to the Verified Company Profile can be expected soon after December 31, 2018.

The predecessor company was the highest banked profit stock for those that traded it correctly in 2017 due to its proven history of regular repeat runs on the excellent financial results each quarter.

It continued to deliver good returns of up to 100% in the first half of 2018 on a number of mini runs.

It also offered a limited opportunity for traders to add shares to their inventory in the .1 > .3 range (previously .0001 > .0003) on August 28 to be ready for "trading-from-the-bottom-up" opportunities as they present themselves over the coming days, weeks and months.

It was obvious that some of the big traders took advantage of this both on August 28 and with additional buys in the .1 > .2 range on August 31 and thereafter.

As predicted in the Rolling Brief Update of September 12, we did indeed see "more buying in the .1 > .2 range - particularly from those that held off buying .0001s on August 28 or .1000 > .1650 since".

The only shares that have been available to buy below .1 have been a total of 18,724 accumulated from insignificant basher / manipulator attempts at paint downs prior to the solid breakout above .1 early on.

The stock has effectively remained above the .1 r/s par for the 15 days since trading recommenced until it broke out above .15 on September 21 with significant buys at .2.

On the next trading day September 24, 2018, a new higher base was established at .25 x .2887 and maintained through to the ticker change.

A higher base was established above .3000 by October 24 with significant buying in the .3000 to .3275 range through to November 2.

This equates to a 220% increase in value for those that were decisive enough to buy .1000s when they had the chance and 60% for those that bought .2000s.

As the traders holding the majority of shares bought in the .1000 to .2500 range were longs / whale repeat traders creating an inventory of shares to trade in the .3000 to .6000 gap - at which point the legacy shares start to return a profit - it is not expected that many shares will be offered up in the .3000 to .4000 range and fills below .3000 are only likely to be insignificant from bashers attempting manipulation to get cheap shares.

Summary of Trading Off The Bottom:

Bought in .0701 > .0999 Range: 18,724 (bids filled by small paint downs)

Bought at .1 (and .0001 pre-r/s): 315,417 [none since Sep 12]

Bought in .1100 > .1499 Range: 85,554 [only 135 since Nov 25]

Bought in .1500 > .1999 Range: 87,182 [only 150 since Nov 25]

Bought in .2000 > .2499 Range: 101,763 [only 11,868 since Oct 12]

Bought in .2500 > .2999 Range: 129,604 [51,616 Oct 18/19]

Bought in .3000 > .3999 Range: 58,149

Bought in .4000 > .4999 Range: 400

A more detailed breakdown by price and day of buying is maintained in the contemporaneous daily updates here.

$ECOX should be thin to the upside with most traders wanting to spin out their holdings of .1s > .3s to trade in the .3 > .6 range for 100% to 500% profit since most holdings above were buys at the equivalent of .4/.5/.6 (and those holdings have all been divided by 1000 now).

An analysis of how thin $ECOX is expected to be to the upside may be found here:

https://investorshangout.com/post/view?id=5216669

The Company’s current (new) business operates an Innovation Incubator platform devoted to globally important paradigm shifts in technology, sustainable products development, and research, to effectively address large known market potentials driven by natural necessity for practical and meaningful change worldwide.

The Company will strategically nurture private companies toward absorption by the Company, or for initial public offerings, strategic joint ventures or other merger and acquisition transactions.

As disclosed in the 2018 Q3 filing, the Company's main asset is an "Available for Sale Security".

On September 17, 2018, a contribution of 20,000,000 common shares of Marijuana Company of America, Inc. was made to the Company.

The shares were valued at $600,000 on this date and resulted in an increase in Additional Paid in Capital.

The Company’s initial project is to prioritize the relaunch of a well-documented, extensively tested, broadly approved and globally celebrated proprietary Affordable Housing Technology, to address the global crisis in affordable housing and construction, whilst effectively addressing the also presently exaggerated worldwide need for secure, extreme-weather and natural catastrophe resistant structures.

On November 12, 2018, the Company entered into an Asset Purchase Agreement with Affordable Rapid Housing, Inc., a Florida corporation (“ARH”). The Company acquired all right, title and interest to certain intellectual properties including possible trademarks, works for hire, trade secrets and related information generally associated with the building, construction and manufacturing trades, methodologies and processes.

The conveyance, assignment, sale, transfer, delivery and grant of the purchased assets by ARH to the Company included all technologies, methods, formulations, databases, trade secrets, knowhow, inventions, complete and incomplete research and development, work in progress, and other intellectual property in any manner related to the purchased assets.

The Company also acquired all records, manuals and other documents relating to or used in connection with the purchased assets, including all information, files, records, data, plans, and contracts and recorded knowledge in whatever form.

Ahead watch out for:

- More buying in the .2500 > .6000 range ahead of the first PR / update from the new company.

- Update to the Verified Company Profile by the TA soon after December 31, 2018.

- First formal PR.

- Any new website or social media account for the new company .

- Price being allowed to rise / moved significantly above .6 at some point as it is now known that the President and Heritage Funding Inc must have bought their shares at .5 / .6 and obviously want a decent return on them.
















American EcoFuels Inc (AEFI) Stock Research Links

AEFI Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 5

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 0

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 5

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 1

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 0

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 2

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 7

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 8

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Cofactor Genomics Appoints New CEO to Enhance Patient Access

Updated Category News Views 169

Cofactor Genomics Appoints Chris Parker as New CEO Cofactor Genomics, Inc., a commercial-stage company dedicated to bridging the precision medicine gap through RNA decoding, has announced a significant leadership transition. Chris Parker has been appointed as the new CEO and Board Member, succeeding Jarret Glasscock, who will continue his contributions in the roles of...

Continue Reading
Minto Apartment REIT Declares Cash Distribution for July 2025

Updated Category News Views 168

Minto Apartment REIT's Cash Distribution Announcement Minto Apartment Real Estate Investment Trust (MI) has recently made an important announcement regarding its cash distribution. The REIT has declared a monthly cash distribution of $0.04333 per unit for the month of July 2025. This translates to an annualized rate of $0.52 per unit. The payment is set to be distributed...

Continue Reading
National Geographic–Lindblad Expands Alaska Offerings for Travelers

Updated Category News Views 89

Expanding Exploration: National Geographic–Lindblad's New Chapter in Alaska National Geographic–Lindblad Expeditions is celebrating a significant milestone in its quest to enhance adventure travel in Alaska, with plans to expand its offerings starting in 2027. The company is known for its pioneering spirit and leadership in expedition travel, and this expansion is a...

Continue Reading
Brian Krause Takes the Helm as Chief Development Officer at Panera

Updated Category News Views 453

Brian Krause Appointed as Chief Development Officer at Panera Bread Panera Bread, a leader in the fast casual dining sector, has recently announced the appointment of Brian Krause as its new Chief Development Officer. With a wealth of experience in franchise development and strategic growth, Krause aims to propel the company's expansion plans. Krause's Experience and...

Continue Reading
Strategic Growth Ahead for Blockmate Ventures with New Funding

Updated Category News Views 115

Blockmate Ventures Expands Its Horizons with New Investment Blockmate Ventures Inc. (TSX.V: MATE), a company recognized for its innovative approach in the tech world, has recently announced a significant investment commitment of CAD $1,400,000. This strategic funding comes from a group of investors, featuring notable industry figure Antanas Guoga, popularly known as Tony...

Continue Reading